University of Louisville, Clinical Trials Unit — Louisville, Kentucky

University of Louisville, Clinical Trials Unit is a clinical research site located in Louisville, Kentucky, United States 40202.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Louisville, Clinical Trials Unit has participated in 6 clinical trials with 3 currently active.

Therapeutic areas: Compensated Cirrhosis, Nonalcoholic Steatohepatitis, Ulcerative Colitis.

Sponsors: Intercept Pharmaceuticals, Alfasigma S.p.A., Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Louisville, Clinical Trials Unit?

University of Louisville, Clinical Trials Unit has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Louisville, Clinical Trials Unit conducted?

University of Louisville, Clinical Trials Unit has 6 clinical trials on record, with 3 currently active. Their work covers Compensated Cirrhosis, Nonalcoholic Steatohepatitis, Ulcerative Colitis.

Is University of Louisville, Clinical Trials Unit accredited by Crixeo Health?

University of Louisville, Clinical Trials Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Louisville, Clinical Trials Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.